Search Results - "Tapper EE"

Differential susceptibility and role for senescence in CART cells based on costimulatory domains.

Authors: Can, Ismail Siegler, Elizabeth L. Sirpilla, Olivia L. et al.

Source: Molecular Cancer. 6/10/2025, Vol. 24 Issue 1, p1-16. 16p.

Updated DPYDHapB3 haplotype structure and implications for pharmacogenomic testing.

Authors: Turner, Amy J. Haidar, Cyrine E. Yang, Wenjian et al.

Source: CTS: Clinical & Translational Science. Jan2024, Vol. 17 Issue 1, p1-7. 7p.

Safety and efficacy of a novel anti-CD19 chimeric antigen receptor T cell product targeting a membrane-proximal domain of CD19 with fast on- and off-rates against non-Hodgkin lymphoma: a first-in-human study.

Authors: Zhang, Yunlin Patel, Ruchi P. Kim, Ki Hyun et al.

Source: Molecular Cancer. 12/9/2023, Vol. 22 Issue 1, p1-23. 23p.

Recent advances in engineered exosome-based therapies for ocular vascular disease.

Authors: Guan, Jian Meng, Fanhe Wang, Chuanzhuo et al.

Source: Journal of Nanobiotechnology. 7/19/2025, Vol. 23 Issue 1, p1-39. 39p.

Impact of pretreatment dihydropyrimidine dehydrogenase genotype‐guided fluoropyrimidine dosing on chemotherapy associated adverse events.

Authors: Wigle, Theodore J. Povitz, Brandi L. Medwid, Samantha et al.

Source: CTS: Clinical & Translational Science. Jul2021, Vol. 14 Issue 4, p1338-1348. 11p.

Long noncoding RNA SNHG6 silencing sensitized esophageal cancer cells to 5-FU via EZH2/STAT pathway.

Authors: Tan, Ran Liu, Jia Wang, Jiang et al.

Source: Scientific Reports. 4/1/2023, Vol. 13 Issue 1, p1-11. 11p.

Endogenous metabolic markers for predicting the activity of dihydropyrimidine dehydrogenase.

Authors: Kang, Jihyun Kim, Andrew HyoungJin Jeon, Inseung et al.

Source: CTS: Clinical & Translational Science. May2022, Vol. 15 Issue 5, p1104-1111. 8p.

Lay understandings of drug‐gene interactions: The right medication, the right dose, at the right time, but what are the right words?

Authors: Meagher, Karen M. Stuttgen Finn, Kelsey Curtis, Susan H. et al.

Source: CTS: Clinical & Translational Science. Mar2022, Vol. 15 Issue 3, p721-731. 11p.

Challenges and strategies associated with CAR-T cell therapy in blood malignancies.

Authors: Liu, Zhaoyun Lei, Wenhui Wang, Hao et al.

Source: Experimental Hematology & Oncology. 2/24/2024, Vol. 13 Issue 1, p1-22. 22p.

DPD status and fluoropyrimidines-based treatment: high activity matters too.

Authors: Chamorey, Emmanuel Francois, Eric Etienne, Marie-Christine et al.

Source: BMC Cancer. 5/18/2020, Vol. 20 Issue 1, p1-9. 9p. 3 Charts, 2 Graphs.

EZH2 Contributes To Cisplatin Resistance In Breast Cancer By Epigenetically Suppressing miR-381 Expression.

Authors: Dou, Dongwei Ge, Xin Wang, Xinxing et al.

Source: OncoTargets & Therapy. Nov2019, Vol. 12, p9627-9637. 11p.

Dose modification for safe treatment of a compound complex heterozygous DPYD variant carrier with 5-fluorouracil.

Authors: Shrestha S Tapper EE Trogstad-Isaacson CS et al.

Source: JCO precision oncology [JCO Precis Oncol] 2018; Vol. 2. Date of Electronic Publication: 2018 Oct 03.

Publication Type: Journal Article

Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2473-4284 (Print) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: PubMed not MEDLINE

EZH2 contributes to 5-FU resistance in gastric cancer by epigenetically suppressing FBXO32 expression.

Authors: Wang, Chenyu Li, Xingwang Zhang, Junjie et al.

Source: OncoTargets & Therapy. Nov2018, Vol. 11, p7853-7864. 12p.

Tumor microenvironment enriches the stemness features: the architectural event of therapy resistance and metastasis.

Authors: Nallasamy, Palanisamy Nimmakayala, Rama Krishna Parte, Seema et al.

Source: Molecular Cancer. 12/22/2022, Vol. 21 Issue 1, p1-25. 25p.

Histone H3K27 Trimethylation Modulates 5-Fluorouracil Resistance by Inhibiting PU.1 Binding to the DPYD Promoter.

Authors: Wu R Nie Q Tapper EE et al.

Source: Cancer research [Cancer Res] 2016 Nov 01; Vol. 76 (21), pp. 6362-6373. Date of Electronic Publication: 2016 Aug 30.

Publication Type: Journal Article; Research Support, N.I.H., Extramural

Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-7445 (Electronic) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE

Bruton tyrosine kinase inhibitors in B-cell lymphoma: beyond the antitumour effect.

Authors: Wang, Haoran Guo, Hao Yang, Jingyi et al.

Source: Experimental Hematology & Oncology. 9/22/2022, Vol. 11 Issue 1, p1-13. 13p.

The significance of exosomal RNAs in the development, diagnosis, and treatment of pancreatic cancer.

Authors: Zhao, Zheng Zhao, Guiping Yang, Shuyue et al.

Source: Cancer Cell International. 7/9/2021, Vol. 21 Issue 1, p1-16. 16p.

Dihydropyrimidine dehydrogenase gene variants for predicting grade 4-5 fluoropyrimidine-induced toxicity: FUSAFE individual patient data meta-analysis.

Authors: Le Teuff G Cozic N Boyer JC et al.

Corporate Authors: Le Teuff G Cozic N Boyer JC et al.

Source: British journal of cancer [Br J Cancer] 2024 Mar; Vol. 130 (5), pp. 808-818. Date of Electronic Publication: 2024 Jan 15.

Publication Type: Meta-Analysis; Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE

Leveraging Immunotherapy in Acute Myeloid Leukemia Treatment: Opportunities and Challenges.

Authors: Fu W Du J Zhong H

Source: Technology in cancer research & treatment [Technol Cancer Res Treat] 2026 Jan-Dec; Vol. 25, pp. 15330338261473431. Date of Electronic Publication: 2026 Jul 24.

Publication Type: Journal Article; Review

Journal Info: Publisher: SAGE Country of Publication: United States NLM ID: 101140941 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1533-0338 (Electronic) Linking ISSN: 15330338 NLM ISO Abbreviation: Technol Cancer Res Treat Subsets: MEDLINE

The Role of Axl Inhibition and Immune Checkpoint Blockade in Non-small Cell Lung Cancer: Current Understanding and Treatment Strategies.

Authors: Kim TW Kim SH DO HJ et al.

Source: Cancer diagnosis & prognosis [Cancer Diagn Progn] 2025 Jun 30; Vol. 5 (4), pp. 417-428. Date of Electronic Publication: 2025 Jun 30 (Print Publication: 2025).

Publication Type: Journal Article; Review

Journal Info: Publisher: International Institute of Anticancer Research Country of Publication: Greece NLM ID: 9918316186306676 Publication Model: eCollection Cited Medium: Internet ISSN: 2732-7787 (Electronic) Linking ISSN: 27327787 NLM ISO Abbreviation: Cancer Diagn Progn Subsets: PubMed not MEDLINE